CN1257175C - 阿德福韦酯晶态、晶态组合物及其制备方法 - Google Patents
阿德福韦酯晶态、晶态组合物及其制备方法 Download PDFInfo
- Publication number
- CN1257175C CN1257175C CN 03100167 CN03100167A CN1257175C CN 1257175 C CN1257175 C CN 1257175C CN 03100167 CN03100167 CN 03100167 CN 03100167 A CN03100167 A CN 03100167A CN 1257175 C CN1257175 C CN 1257175C
- Authority
- CN
- China
- Prior art keywords
- crystalline state
- adefovir ester
- adefovir
- composition
- solvent
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Images
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
Claims (5)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 03100167 CN1257175C (zh) | 2003-01-08 | 2003-01-08 | 阿德福韦酯晶态、晶态组合物及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 03100167 CN1257175C (zh) | 2003-01-08 | 2003-01-08 | 阿德福韦酯晶态、晶态组合物及其制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1425673A CN1425673A (zh) | 2003-06-25 |
CN1257175C true CN1257175C (zh) | 2006-05-24 |
Family
ID=4789786
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN 03100167 Expired - Fee Related CN1257175C (zh) | 2003-01-08 | 2003-01-08 | 阿德福韦酯晶态、晶态组合物及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN1257175C (zh) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2004043972A1 (fr) * | 2002-11-12 | 2004-05-27 | Tianjin Kinsly Pharmaceutical Co., Ltd. | Nouvelle forme cristalline d'adefovir dipivoxil et sa composition |
CN100415756C (zh) * | 2003-10-14 | 2008-09-03 | 沈阳药科大学 | 草酸阿地福韦酯及其晶型和制备方法及用途 |
CN101054393B (zh) * | 2006-04-11 | 2011-08-17 | 上海现代制药股份有限公司 | 阿德福韦酯无水结晶物、其制备方法以及药物组合物 |
CN101684129B (zh) * | 2007-09-05 | 2012-05-23 | 福建广生堂药业股份有限公司 | 一种阿德福韦酯m晶型的制备方法 |
-
2003
- 2003-01-08 CN CN 03100167 patent/CN1257175C/zh not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
CN1425673A (zh) | 2003-06-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN1487921A (zh) | 非结晶阿托伐他汀钙的制备 | |
JPS59222475A (ja) | 二相薬剤組成物 | |
CN1406238A (zh) | N-[4-[2-(2-氨基-4,7-二氢-4-氧代-3H-吡咯并[2,3-d]嘧啶-5-基)乙基]苯甲酰基]-L-谷氨酸的一种新晶形及其制备方法 | |
EP1940364A2 (en) | Capsule formulation of pirfenidone and pharmaceutically acceptable excipients | |
US4992277A (en) | Immediate release diltiazem formulation | |
CN1257175C (zh) | 阿德福韦酯晶态、晶态组合物及其制备方法 | |
EP2332941A2 (en) | Stabilized solid dispersion of adefovir dipivoxil and preparation method thereof | |
AU659114B2 (en) | Method for the manufacture of a controlled release solid unit dosage form | |
EP1987814A1 (en) | Mifepristone pharmaceutical compositions and their methods of preparation | |
CN1921839A (zh) | 加巴喷丁的稳定缓释口服剂型及其制备方法 | |
IL276430B1 (en) | Salt of 1-methyl(-1H-pyrazol-4-yl)-5-(4-(trifluoromethoxy)phenyl)-1,5-dihydro-H4-imidazo[4,5c]pyridin-4-one, pharmaceutical preparations including the salt and the processes for the preparation of the salt and the composition | |
CN102176902B (zh) | 有机溶剂在莫西沙星湿法造粒中的应用 | |
CN1847252A (zh) | 无定形阿德福韦酯的制备方法及其药物组合物 | |
CN1374314A (zh) | 阿德福韦酯无定形固化物及制备方法 | |
EP2568810B1 (en) | Darunavir compositions | |
CN103054820A (zh) | 一种盐酸决奈达隆药物组合物及其制备方法 | |
CN1807417A (zh) | 新型无水无结晶型态的罗伐他汀钙盐 | |
WO2004087660A1 (en) | A novel process for amorphous form of donepezil hydrochloride | |
CN101054393A (zh) | 阿德福韦酯无水结晶物、其制备方法以及药物组合物 | |
EP0740934A1 (de) | Arzneizubereitungen mit kontrollierter Freisetzung und Verfahren zu ihrer Herstellung | |
WO2004087681A1 (en) | A novel amorphous form of valsartan | |
CN1636565A (zh) | R(-)-n-(4,4-二(3-甲基噻吩-2-基)丁-3-烯基)-3-哌啶甲酸盐酸盐的改进形式 | |
CN1679596B (zh) | 无结晶型态的阿地福韦酯与辅料的分散组合物及其制备方法 | |
CN1310891C (zh) | N-哌啶基-1-(2,4-二氯苯基)-4-甲基-5-(4-氯苯基)吡唑-3-甲酰胺有机酸盐及其药物组合物 | |
EP3628310A1 (en) | Pharmaceutical composition comprising solid dispersions of amorphous cladribine and pharmaceutically acceptable water soluble carrier |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
ASS | Succession or assignment of patent right |
Owner name: SUZHOU ERYE PHARMACEUTICAL CO., LTD. Free format text: FORMER OWNER: BOERDA BIOLOGICAL TECHNOLOGY DEVELOPMENT CO., LTD., BEIJING Effective date: 20070309 |
|
C41 | Transfer of patent application or patent right or utility model | ||
TR01 | Transfer of patent right |
Effective date of registration: 20070309 Address after: 215002 No. 859 Xu Lu, Suzhou Patentee after: Suzhou Erye Pharmaceutical Co., Ltd. Address before: 100024, Beijing Chaoyang District Guanzhuang Yang gate around the Yanjing pharmaceutical research building 3 Patentee before: Boerda Biotech Development Co., Ltd., Beijing |
|
C56 | Change in the name or address of the patentee | ||
CP02 | Change in the address of a patent holder |
Address after: 215002 Jiangsu city of Suzhou Province Huang Dai Zhen An min Lu, Xiangcheng District Patentee after: Suzhou Erye Pharmaceutical Co., Ltd. Address before: No 859 Xu Lu, Suzhou, Jiangsu Patentee before: Suzhou Erye Pharmaceutical Co., Ltd. |
|
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20060524 Termination date: 20200108 |
|
CF01 | Termination of patent right due to non-payment of annual fee |